Pharmacokinetics and tissue distribution of 3-((5-(6-methylpyridin-2-yl)-4-(quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzamide; a novel ALK5 inhibitor and a potential anti-fibrosis drug. [electronic resource]
Producer: 20081003Description: 325-39 p. digitalISSN:- 0049-8254
- Administration, Oral
- Animals
- Benzamides -- administration & dosage
- Biological Transport -- drug effects
- Caco-2 Cells
- Chromatography, Liquid
- Dogs
- Enzyme Inhibitors -- administration & dosage
- Half-Life
- Haplorhini
- Humans
- Imidazoles -- administration & dosage
- Injections, Intravenous
- Magnetic Resonance Spectroscopy
- Male
- Mass Spectrometry
- Mice
- Models, Biological
- Protein Serine-Threonine Kinases -- antagonists & inhibitors
- Quinoxalines -- administration & dosage
- Rats
- Rats, Sprague-Dawley
- Receptor, Transforming Growth Factor-beta Type I
- Receptors, Transforming Growth Factor beta -- antagonists & inhibitors
- Tissue Distribution -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.